Zhi Hong, Brii Biosciences CEO
Another Covid-19 antibody cocktail on the menu? Brii Bio touts early win in NIH study for a combo already used in China
Months after flopping in an NIH-sponsored study, Brii Biosciences’ Covid-19 antibody combo has redeemed itself in a second trial.
The biotech says its antibodies …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
